← Eichor
Study identifier: NCT07730138 Synced from ClinicalTrials.gov · July 28, 2026
● Not Yet Recruiting

Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer

Condition: Gastric Ulcer  ·  Sponsor: Daewoong Pharmaceutical Co. LTD.

PhasePhase 3
Planned participants384
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

A Multinational, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group, Phase 3 Study to Evaluate the Efficacy and Safety of DWP14012 in Participants with Gastric Ulcer

This description comes directly from the study's public registry record.

Talk to the study team

Hokyun Yoo  ·  +82)02-550-8800  ·  2220160@daewoong.co.kr

Always discuss trial participation with your own doctor first.

Locations (2)

RS Cipto MangunkusumoJakarta, Indonesia—
The Catholic University of Korea, Incheon St. Mary'S HospitalIncheon, South Korea—

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07730138